tiprankstipranks
Aspen Pharmacare (DE:LDZU)
FRANKFURT:LDZU
Germany Market
LDZU
Aspen Pharmacare
RESEARCH TOOLSreports

Aspen Pharmacare (LDZU) Ratios

1 Followers

Aspen Pharmacare Ratios

DE:LDZU's free cash flow for Q4 2026 was Rs0.37. For the 2026 fiscal year, DE:LDZU's free cash flow was decreased by Rs and operating cash flow was Rs0.13. See a summary of the company’s cash flow.
Ratios
TTM
Jun 26Jun 25Jun 24Jun 23
Liquidity Ratios
Current Ratio
 2.54 2.54 2.21 1.81 1.92
Quick Ratio
 1.68 1.68 1.18 1.07 1.08
Cash Ratio
 0.99 0.99 0.37 0.51 0.47
Solvency Ratio
 0.16 0.16 >-0.01 0.12 0.14
Operating Cash Flow Ratio
 0.42 0.42 0.29 0.26 0.24
Short-Term Operating Cash Flow Coverage
 1.13 1.12 1.12 0.56 0.71
Net Current Asset Value
Rs 13.38BRs 13.27BRs -12.30BRs -10.21BRs -3.55B
Leverage Ratios
Debt-to-Assets Ratio
 0.14 0.14 0.27 0.26 0.22
Debt-to-Equity Ratio
 0.19 0.19 0.43 0.43 0.34
Debt-to-Capital Ratio
 0.16 0.16 0.30 0.30 0.25
Long-Term Debt-to-Capital Ratio
 0.11 0.11 0.27 0.23 0.20
Financial Leverage Ratio
 1.35 1.35 1.60 1.64 1.56
Debt Service Coverage Ratio
 0.90 0.89 0.19 0.65 0.98
Interest Coverage Ratio
 3.51 3.51 0.87 3.14 5.91
Debt to Market Cap
 0.22 0.23 0.68 0.36 0.36
Interest Debt Per Share
 38.58 38.17 85.03 87.08 68.90
Net Debt to EBITDA
 -0.06 -0.06 13.75 2.44 1.80
Profitability Margins
Gross Profit Margin
40.31%40.31%44.11%43.43%45.22%
EBIT Margin
15.48%15.48%3.52%17.76%21.93%
EBITDA Margin
20.98%20.98%4.98%22.16%25.03%
Operating Profit Margin
15.48%15.48%3.31%15.65%19.21%
Pretax Profit Margin
-1.20%-1.20%-0.28%12.78%16.10%
Net Profit Margin
7.59%7.59%-2.50%9.85%12.84%
Continuous Operations Profit Margin
-2.55%-2.55%-2.50%9.85%12.84%
Net Income Per EBT
-633.25%-633.25%880.49%77.07%79.76%
EBT Per EBIT
-7.74%-7.74%-8.56%81.65%83.80%
Return on Assets (ROA)
2.44%2.41%-0.80%3.16%3.89%
Return on Equity (ROE)
3.28%3.25%-1.28%5.19%6.06%
Return on Capital Employed (ROCE)
5.87%5.79%1.21%6.10%7.04%
Return on Invested Capital (ROIC)
5.50%5.43%1.17%4.28%5.24%
Return on Tangible Assets
4.08%4.03%-1.71%6.54%7.97%
Earnings Yield
3.80%3.79%-2.03%4.40%6.41%
Efficiency Ratios
Receivables Turnover
 69.19 68.29 3.25 3.90 4.04
Payables Turnover
 2.22 2.19 2.27 5.78 5.62
Inventory Turnover
 1.49 1.47 1.35 1.40 1.14
Fixed Asset Turnover
 1.69 1.67 2.00 2.18 2.15
Asset Turnover
 0.32 0.32 0.32 0.32 0.30
Working Capital Turnover Ratio
 1.05 1.48 2.12 2.18 2.50
Cash Conversion Cycle
 86.29 87.42 222.74 290.32 346.37
Days of Sales Outstanding
 5.28 5.34 112.28 93.61 90.44
Days of Inventory Outstanding
 245.32 248.54 271.24 259.82 320.89
Days of Payables Outstanding
 164.31 166.46 160.78 63.10 64.96
Operating Cycle
 250.60 253.88 383.52 353.42 411.33
Cash Flow Ratios
Operating Cash Flow Per Share
 15.49 15.15 11.61 14.01 12.43
Free Cash Flow Per Share
 10.66 10.42 0.23 1.55 5.27
CapEx Per Share
 4.83 4.72 11.38 12.46 7.16
Free Cash Flow to Operating Cash Flow
 0.69 0.69 0.02 0.11 0.42
Dividend Paid and CapEx Coverage Ratio
 2.23 2.23 0.78 0.88 1.19
Capital Expenditure Coverage Ratio
 3.21 3.21 1.02 1.12 1.74
Operating Cash Flow Coverage Ratio
 0.44 0.44 0.14 0.17 0.19
Operating Cash Flow to Sales Ratio
 0.20 0.20 0.12 0.14 0.14
Free Cash Flow Yield
6.78%6.76%0.20%0.69%2.87%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 26.34 26.62 -49.19 22.73 15.61
Price-to-Sales (P/S) Ratio
 2.00 2.00 1.23 2.24 2.01
Price-to-Book (P/B) Ratio
 0.87 0.86 0.63 1.18 0.95
Price-to-Free Cash Flow (P/FCF) Ratio
 14.74 14.78 512.59 145.09 34.90
Price-to-Operating Cash Flow Ratio
 10.14 10.17 10.33 16.08 14.79
Price-to-Earnings Growth (PEG) Ratio
 -0.53 -0.08 0.39 -1.44 -0.88
Price-to-Fair Value
 0.87 0.86 0.63 1.18 0.95
Enterprise Value Multiple
 9.47 9.49 38.42 12.54 9.81
Enterprise Value
 69.28B 68.01B 83.02B 124.23B 99.99B
EV to EBITDA
 9.47 9.49 38.42 12.54 9.81
EV to Sales
 1.99 1.99 1.91 2.78 2.46
EV to Free Cash Flow
 14.65 14.69 798.27 180.04 42.75
EV to Operating Cash Flow
 10.09 10.11 16.09 19.96 18.11
Tangible Book Value Per Share
 83.38 82.60 28.09 29.37 39.48
Shareholders’ Equity Per Share
 181.23 179.53 191.11 191.04 194.14
Tax and Other Ratios
Effective Tax Rate
 -1.12 -1.12 -7.80 0.23 0.20
Revenue Per Share
 78.63 76.88 97.62 100.64 91.65
Net Income Per Share
 5.97 5.84 -2.44 9.91 11.77
Tax Burden
 -6.33 -6.33 8.80 0.77 0.80
Interest Burden
 -0.08 -0.08 -0.08 0.72 0.73
Research & Development to Revenue
 0.00 0.00 0.00 <0.01 <0.01
SG&A to Revenue
 0.25 0.25 0.25 0.08 0.04
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 <0.01 <0.01
Income Quality
 -7.74 -7.74 3.59 0.89 0.71
Currency in ZAR